Products

Glooko Diabetes Management
Glooko
Endocrinology & Metabolic AI
Glooko is a leading diabetes management platform that unifies data from over 200 diabetes and health monitoring devices, integrates with EHRs, and provides actionable insights for healthcare providers, hospitals, and people with diabetes.

See all 1 product →

About Glooko

Glooko is a global digital health company that provides a comprehensive, connected care platform designed to simplify diabetes and chronic condition management for healthcare providers and patients. The platform unifies data from over 200 diabetes and health monitoring devices, including blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, and activity trackers, into a single, secure, and EHR-integrated solution. This aggregation of data allows clinicians, including endocrinologists, nurses, diabetes educators, and primary care providers, to gain a holistic view of their patients’ health, enabling more informed treatment decisions and personalized care plans.

For physicians, Glooko’s platform streamlines clinical workflows by integrating seamlessly with leading Electronic Health Record (EHR) systems such as Epic, Oracle Health, and MEDITECH. This integration reduces administrative burden, eliminates the need for manual data entry and platform switching, and helps combat clinician burnout by centralizing critical patient data. The company leverages AI-enabled insights and advanced analytics to identify at-risk patients, forecast glycemic events, and support remote patient monitoring (RPM) efforts, thereby enhancing glycemic safety and improving patient outcomes across both outpatient and inpatient settings.

Beyond direct patient care, Glooko also partners with life sciences companies to utilize real-world device data for accelerating clinical development, optimizing site selection, and gaining privacy-safe insights into patient journeys. The platform supports digital therapeutics and aims to transform chronic condition management by turning data into actionable insights that drive better outcomes for people with diabetes and other chronic conditions.

What Physicians Need to Know

Specialization
Glooko specializes in comprehensive diabetes management, offering a connected care platform for both outpatient and inpatient glycemic management.
Device Integration
The platform unifies data from over 200 diabetes and health monitoring devices, including continuous glucose monitors (CGMs), insulin pumps, blood glucose meters (BGMs), insulin pens, activity trackers, blood pressure monitors, and smart scales.
Actionable Insights
Glooko provides comprehensive charts, graphs, and pattern recognition to help clinicians quickly identify risks and trends, facilitating data-driven conversations and personalized treatment strategies.
Workflow Efficiency
It streamlines clinical workflows by reducing administrative burden, eliminating the need for platform switching, and supporting remote collaboration between patients and care teams.
Proven Outcomes
Glooko has demonstrated proven clinical outcomes, including reductions in HbA1c levels, increased patient adherence, and fewer diabetes-related hospitalizations.
Key Differentiator: Device Agnostic
A significant differentiator is its device-agnostic approach, integrating with the largest ecosystem of over 200 diabetes and health monitoring devices.
Key Differentiator: EHR Integration
Glooko offers seamless integration with leading EHR systems such as Epic, Cerner, NextGen, Athenahealth, Oracle Health, MEDITECH, Greenway Health, and eClinicalWorks, utilizing SMART on FHIR and HL7 v2 standards.
Key Differentiator: Security & Compliance
The company maintains a strong security posture with multiple top-tier global security and privacy certifications, including HITRUST r2, ISO 27001, SOC 2 Type II, and SOC 3, ensuring HIPAA and GDPR compliance.
Technology Stack Highlights
Glooko leverages interoperability standards like HL7 v2 and SMART on FHIR. Its data management relies on Postgres with Tiger Data (TimescaleDB hypertables) for time-series data, with AWS forming the backbone of its digital system. The platform also offers APIs for commercial customers and a mobile app for patients. Future developments include AI-driven predictive analytics.
Physician Tip

For physicians, Glooko stands out by significantly reducing administrative burden and clinician burnout through streamlined workflows and timely access to comprehensive patient data directly within the EHR. The platform's ability to unify data from over 200 devices provides a holistic view, enhancing clinical decision-making and enabling more informed, personalized, and proactive treatment strategies. This leads to improved patient outcomes, including better glycemic control and reduced hospitalizations. Glooko also facilitates effective remote patient monitoring and collaboration, while its robust security certifications ensure patient data privacy and trust. The comprehensive approach, covering both outpatient and inpatient care, offers a unified solution for diabetes management.

Glooko offers extensive EHR integrations with leading systems (Epic, Cerner, NextGen, Athenahealth, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks) using SMART on FHIR and HL7 v2 for seamless data centralization. It also integrates with over 200 diabetes and health monitoring devices. Commercial customers can leverage Glooko's APIs for deeper integration, enabling automated patient account creation, data retrieval, and notifications.

Products by Glooko

1 product in the directory

Glooko Diabetes Management
Glooko
Endocrinology & Metabolic AI
Glooko is a leading diabetes management platform that unifies data from over 200 diabetes and health monitoring devices, integrates with EHRs, and provides actionable insights for healthcare providers, hospitals, and people with diabetes.

What the Web Says

Glooko is a digital health company focused on diabetes management, offering a platform and mobile app to help individuals and healthcare providers track and manage diabetes data. The platform integrates with over 200 diabetes and health monitoring devices, aiming to simplify care and improve health outcomes. While many users find the app helpful for consolidating data and generating reports, some have experienced issues with manual data entry, food logging, and app functionality. Employer reviews indicate a mixed sentiment, with some praising the culture and colleagues, while others point to concerns about leadership, growth opportunities, and training.

Overall: Mixed

Strengths

  • Aggregates data from various diabetes devices and fitness trackers into one platform.
  • Easy to set up and use for many individuals.
  • Provides comprehensive reports that can be helpful for understanding trends and discussing with healthcare providers.
  • Offers a clear overview of blood glucose, insulin, and carb data.
  • Can empower patients to better manage their condition.
  • Collaborative and smart team environment with passionate coworkers (employer review).

Limitations

  • Issues with manual blood glucose entry and syncing with Apple Health for some users.
  • Food logging can be difficult and the food library may be limited or inaccurate, especially in non-US versions.
  • Some users report the app can be confusing to navigate for detailed insights.
  • Proprietary cables were historically a gripe for some users.
  • Executive leadership is described as undisciplined, with frequent changes in business direction and reorganizations (employer review).
  • Limited growth opportunities and difficult to obtain clear answers or thorough training (employer review).

Based on reviews from: Reddit, FeaturedCustomers, Apple App Store, Indeed.com, Comparably

Last updated: 2026-07-21

Videos

News, demos, and interviews about Glooko.

Loading videos...

Videos load interactively. If none appear, search YouTube for Glooko →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Glooko's platform unifies data from over 200 diabetes and health monitoring devices, providing actionable insights for clinicians. Through its acquisition of xbird, Glooko incorporates AI and machine learning for predictive analytics, including forecasting hypoglycemic/hyperglycemic events and enabling Just-in-Time Adaptive Interventions (JITAI) to support diabetes management.
Glooko is fully compliant with major healthcare regulations including HIPAA, GDPR, CCPA, and LGPD. The company holds industry-leading certifications such as HITRUST Risk-based, 2-year (r2) Certification, ISO 27001, SOC 2 Type II, and SOC 3, demonstrating robust data security and privacy controls.
While the Glooko mobile app is free for individual patients, Glooko offers different versions of its Population Tracker for healthcare providers, including 'Basic' and 'Enterprise' options. Specific pricing for clinics and hospitals is typically determined through direct engagement with Glooko's sales team, as it can vary based on the scale of implementation and features required.
Glooko offers comprehensive support services, including a 24/7 online help center, email, phone support, and live chat during business hours. They also provide dedicated customer success managers and expert teams to assist with EHR integrations and optimize platform utilization for healthcare providers.
Glooko integrates with over 200 diabetes and health monitoring devices and major Electronic Health Record (EHR) systems such as Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth. These integrations leverage technologies like SMART on FHIR and HL7 to centralize patient data, reduce administrative burden, and enhance clinical decision-making.
Founded in 2010, Glooko demonstrates strong company stability, having raised over $201 million in total funding across eight rounds, including a significant $100 million Series F round in October 2024. The company has also expanded its offerings through strategic acquisitions like xbird and Monarch Medical Technologies, indicating continued growth and market presence.
Glooko's platform helps improve patient outcomes by providing timely access to comprehensive glucose and health data, enabling more informed treatment decisions and enhancing patient safety. For clinicians, it streamlines workflows by unifying data from multiple devices and integrating with EHRs, reducing administrative burden and allowing more focus on direct patient care, thereby mitigating burnout.

Investors

Who's funded Glooko.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.